| Literature DB >> 32982256 |
Ting Ni1, Yaping Meng1, Yuhong Li1, Qinfang Chen1, Yong Huang1, Lihua Wang1, Xiaolei Qian1, Yudong Wang1,2,3.
Abstract
OBJECTIVE: This study aimed to provide insight into the effect of time interval between loop electrosurgical excision procedure (LEEP) and subsequent hysterectomy on postoperative infectious morbidity in cervical neoplasia patients.Entities:
Keywords: LEEP; cervical cancer; hysterectomy; time interval
Year: 2020 PMID: 32982256 PMCID: PMC7490066 DOI: 10.2147/TCRM.S270590
Source DB: PubMed Journal: Ther Clin Risk Manag ISSN: 1176-6336 Impact factor: 2.423
Figure 1The distribution of time interval between loop electrosurgical excision procedures (LEEP) and subsequent hysterectomy for our population by surgical approach.
Patient Baseline Characteristics by Time Interval Tertiles
| Time Interval (Days) | T1 | T2 | T3 | P-value |
|---|---|---|---|---|
| N | 378 | 400 | 394 | |
| Age (years) | 0.788 | |||
| <65 | 361 (95.50%) | 380 (95.00%) | 372 (94.42%) | |
| ≥65 | 17 (4.50%) | 20 (5.00%) | 22 (5.58%) | |
| History of pregnancy | 0.923 | |||
| No | 8 (2.12%) | 9 (2.25%) | 10 (2.54%) | |
| Yes | 370 (97.88%) | 391 (97.75%) | 384 (97.46%) | |
| Menopause | 0.188 | |||
| No | 258 (68.25%) | 275 (68.75%) | 249 (63.20%) | |
| Yes | 120 (31.75%) | 125 (31.25%) | 145 (36.80%) | |
| Hypertension | 0.383 | |||
| No | 338 (89.42%) | 345 (86.25%) | 343 (87.06%) | |
| Yes | 40 (10.58%) | 55 (13.75%) | 51 (12.94%) | |
| Diabetes mellitus | 0.102 | |||
| No | 369 (97.62%) | 385 (96.25%) | 373 (94.67%) | |
| Yes | 9 (2.38%) | 15 (3.75%) | 21 (5.33%) | |
| Histologic subtype | 0.004 | |||
| Squamous | 349 (92.33%) | 359 (89.75%) | 378 (95.94%) | |
| Non-squamous | 29 (7.67%) | 41 (10.25%) | 16 (4.06%) | |
| Surgical approach | 0.010 | |||
| Vaginal | 53 (14.02%) | 37 (9.25%) | 55 (13.96%) | |
| Laparoscopic | 197 (52.12%) | 252 (63.00%) | 236 (59.90%) | |
| Open | 128 (33.86%) | 111 (27.75%) | 103 (26.14%) | |
| Type of hysterectomy | <0.001 | |||
| Non-radical | 227 (60.05%) | 255 (63.75%) | 347 (88.07%) | |
| Radical | 151 (39.95%) | 145 (36.25%) | 47 (11.93%) | |
| Previous abdominal surgery | 0.557 | |||
| No | 242 (64.02%) | 253 (63.25%) | 263 (66.75%) | |
| Yes | 136 (35.98%) | 147 (36.75%) | 131 (33.25%) | |
| Blood transfusion | 0.150 | |||
| No | 370 (97.88%) | 394 (98.50%) | 392 (99.49%) | |
| Yes | 8 (2.12%) | 6 (1.50%) | 2 (0.51%) | |
| Intraoperative complication | 0.618 | |||
| No | 376 (99.47%) | 397 (99.25%) | 393 (99.75%) | |
| Yes | 2 (0.53%) | 3 (0.75%) | 1 (0.25%) | |
| Noninfectious postoperative complications | 0.718 | |||
| No | 373 (98.68%) | 395 (98.75%) | 391 (99.24%) | |
| Yes | 5 (1.32%) | 5 (1.25%) | 3 (0.76%) | |
| Stage | <0.001 | |||
| HSIL | 127 (33.60%) | 145 (36.25%) | 265 (67.26%) | |
| Invasive cancer | 251 (66.40%) | 255 (63.75%) | 129 (32.74%) | |
| Operative time (min) | <0.001 | |||
| <180 | 226 (59.79%) | 250 (62.50%) | 327 (82.99%) | |
| ≥180 | 152 (40.21%) | 150 (37.50%) | 67 (17.01%) | |
| Estimated blood loss (mL) | <0.001 | |||
| <300 | 316 (83.60%) | 358 (89.50%) | 368 (93.40%) | |
| ≥300 | 62 (16.40%) | 42 (10.50%) | 26 (6.60%) |
Notes: Time interval tertile: T1 median (range): 11 (0–16) days, T2: 24 (17–33) days and T3: 48 (34–90) days. P< 0.05 was considered significantly important.
Abbreviation: HSIL, high grade cervical intraepithelial neoplasia.
Details of Perioperative Complications
| N (%) | |
|---|---|
| Infectious morbidity | |
| SSI | |
| No | 1139 (97.18%) |
| Yes | 33 (2.82%) |
| NSSI | |
| No | 1102 (94.03%) |
| Yes | 70 (5.97%) |
| Febrile | |
| No | 1063 (90.70%) |
| Yes | 109 (9.30%) |
| Intraoperative complication | |
| Ureteral injury | 3 (0.26%) |
| Internal iliac vein injury | 1 (0.09%) |
| Bowel injury | 1 (0.09%) |
| Vaginal injury | 1 (0.09%) |
| Noninfectious postoperative complications | |
| Venous thromboembolism | 2 (0.17%) |
| Lymphocele | 2 (0.17%) |
| Lymphorrhea | 1 (0.09%) |
| Bowel obstruction | 4 (0.34%) |
| Cuff dehiscence | 1 (0.09%) |
| Delirium | 1 (0.09%) |
| Gastrointestinal disorders | 2 (0.17%) |
Abbreviations: SSI, surgical site infection; NSSI, nonsurgical site infection.
Effect of Risk Factors on Infectious Morbidity
| Statistics | Infectious Morbidity | |
|---|---|---|
| Age(years) | ||
| <65 | 1113 (94.97%) | 1.0 |
| ≥65 | 59 (5.03%) | 0.71 (0.33,1.51) 0.3726 |
| Diabetes mellitus | ||
| No | 1127 (96.16%) | 1.0 |
| Histologic subtype | ||
| Squamous | 1086 (92.66%) | 1.0 |
| Non-squamous | 86 (7.34%) | 1.23 (0.72, 2.12) 0.4500 |
| Surgical approach | ||
| Vaginal | 145 (12.37%) | 1.0 |
| Laparoscopic | 685 (58.45%) | 0.57 (0.36, 0.90) 0.0169 |
| Open | 342 (29.18%) | 1.56 (0.98, 2.50) 0.0635 |
| Type of hysterectomy | ||
| Non-radical | 829 (70.73%) | 1.0 |
| Radical | 343 (29.27%) | 3.71 (2.72, 5.05) <0.0001 |
| Operative time (min) | ||
| <180 | 803 (68.52%) | 1.0 |
| ≥180 | 369 (31.48%) | 3.63 (2.67, 4.94) <0.0001 |
| Estimated blood loss (mL) | ||
| <300 | 1042 (88.91%) | 1.0 |
| ≥300 | 130 (11.09%) | 4.90 (3.33, 7.21) <0.0001 |
| Stage | ||
| HSIL | 537 (45.82%) | 1.0 |
| Invasive cancer | 635 (54.18%) | 3.28 (2.33, 4.62) <0.0001 |
Note: P< 0.05 was considered significantly important.
Abbreviations: HSIL, high grade cervical intraepithelial neoplasia; OR, odds ratio; CI, confidence interval.
Univariate and Multivariate Analysis Between Time Interval and Infectious Morbidity
| Crude | Adjusted | |
|---|---|---|
| Infectious morbidity | ||
| Time interval (continuous) | 0.98 (0.97, 0.98) <0.0001 | 0.99 (0.98, 1.00) 0.0079 |
| Time interval (tertile) | ||
| T1 | 1.0 | 1.0 |
| T2 | 0.66 (0.47, 0.94) 0.0196 | 0.76 (0.53, 1.11) 0.154 |
| T3 | 0.41 (0.28, 0.60) <0.0001 | 0.66 (0.43, 1.00) 0.0487 |
Notes: Adjust model adjusted for:Stage; Surgical approach; Operative time; Estimated blood loss. Time interval tertile: T1 median (range): 11 (0–16) days, T2: 24 (17–33) days and T3: 48 (34–90) days. P< 0.05 was considered significantly important.
Abbreviations: OR, odds ratio; CI, confidence interval.
Figure 2The incidence of infectious morbidity in time interval tertile stratified by surgical approach. Time interval tertile: T1 median (range): 11 (0–16) days, T2: 24 (17–33) days and T3: 48 (34–90) days.
Figure 3Smooth curves between time interval and postoperative infectious morbidity stratified by surgical approach. The model was adjusted for stage, operative time and estimated blood loss.
Subgroup Analysis and Interaction Test Between Covariates and Time Interval on Infectious Morbidity
| Subgroup | T1 | T2 | T3 |
|---|---|---|---|
| Stage | |||
| HSIL | 1.0 | 0.39 (0.16, 1.01) 0.0516 | 0.66 (0.33, 1.36) 0.2614 |
| Invasive cancer | 1.0 | 0.86 (0.57, 1.30) 0.4785 | 0.58 (0.34, 1.01) 0.0536 |
| P interaction | 0.1565 | ||
| Surgical approach | |||
| Vaginal | 1.0 | 0.99 (0.34, 2.93) 0.9906 | 0.71 (0.26, 1.92) 0.5024 |
| Laparoscopic | 1.0 | 0.72 (0.42, 1.23) 0.2264 | 0.37 (0.17, 0.78) 0.0095 |
| Open | 1.0 | 0.63 (0.34, 1.16) 0.1394 | 0.93 (0.49, 1.78) 0.8347 |
| P interaction | 0.0352 | ||
| Operative time (min) | |||
| <180 | 1.0 | 0.71 (0.40, 1.25) 0.2330 | 0.65 (0.37, 1.14) 0.1359 |
| ≥180 | 1.0 | 0.80 (0.49, 1.32) 0.3807 | 0.69 (0.35, 1.37) 0.2874 |
| P interaction | 0.7333 | ||
| Estimated blood loss (mL) | |||
| <300 | 1.0 | 0.70 (0.46, 1.06) 0.0925 | 0.62 (0.39, 0.98) 0.0428 |
| ≥300 | 1.0 | 1.18 (0.51, 2.74) 0.7070 | 0.83 (0.29, 2.34) 0.7225 |
| P interaction | 0.6886 | ||
Notes: Each stratification adjusted for all the factors (stage, surgical approach, operative time and estimated blood loss) except the stratification factor itself. Time interval tertile: T1 median (range): 11 (0–16) days, T2: 24 (17–33) days and T3: 48 (34–90) days. P< 0.05 was considered significantly important.
Abbreviations: HSIL, high grade cervical intraepithelial neoplasia; OR, odds ratio; CI, confidence interval.